Respiratory rehabilitation to improve sleep in COPD
Official title: Benefit of Respiratory Rehabilitation on Objective Sleep Quality in Patients With Stable COPD
Run by University Hospital, Rouen · NCT06677268 · Data updated 2026-11-12
This trial will test whether a respiratory rehabilitation program can improve sleep quality measured by overnight polysomnography in people aged 50 and older with stable COPD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University Hospital, Rouen Academic / other |
| Locations | 4 sites (Amiens and 3 other locations) |
| Status | Recruiting |
| Started | February 19, 2025 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT06677268 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 50 or older with stable COPD (per GOLD criteria) who have not had respiratory rehabilitation in the past 12 months and who do not have obesity (BMI < 30) or previously diagnosed obstructive sleep apnea.
✕Probably not a fit
Patients with BMI ≥ 30, known OSA (AHI > 10/h), those using CPAP or NIV, on systemic corticosteroids or sedating central nervous system drugs, or with recent severe exacerbations are unlikely to be eligible or may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Stable COPD patients aged 50 and older who are eligible for pulmonary rehabilitation will have baseline clinical testing and overnight polysomnography to document sleep architecture. Participants will then complete a structured respiratory rehabilitation program combining supervised exercise training and patient education over several weeks. After the program, repeat polysomnography and clinical measures (daytime oxygenation, dyspnea scores, exercise capacity, and quality of life) will be obtained to compare sleep stages and sleep onset latency. The study focuses on objective changes in sleep architecture and related symptoms to see if rehabilitation can modify sleep disturbances in COPD.
Why it matters
Potential benefit: If successful, the program could improve sleep quality and deep sleep, reduce daytime breathlessness, and lower the risk of COPD exacerbations.
How similar studies have gone: Respiratory rehabilitation has established benefits for exercise capacity, dyspnea, and quality of life in COPD, but few studies have used polysomnography to demonstrate clear improvements in objective sleep architecture, making this application partly novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female ≥ age 50 * COPD defined according to the GOLD 2022 criteria, clinically stable (without exacerbation for at least 4 weeks), with indication for respiratory rehabilitation * Absence of respiratory rehabilitation in the past 12 months * Patient affiliated to the social security system * For women of childbearing potential who have been on effective contraception (estrogen-progestogen or intrauterine device or tubal ligation) for 1 month. * For postmenopausal women: confirmatory diagnosis (non-medically induced amenorrhea for at least 12 months prior to the inclusion visit) * Patient who has read and understood the information letter and signed the consent form Exclusion Criteria: * BMI≥ 30 kg/m2 * Previously documented OSA (AHI \> 10/h) * Patient with a CPAP or NIV * Patient on systemic corticosteroid therapy * Patient on centrally acting therapy (benzodiazepine or opiate) * Patient with an occurrence of severe COPD exacerbation * Patient with other associated chronic respiratory insufficiency * Patient with active cancer * Patient with neuromuscular disease * Patient with an osteoarticular disability or traumatic or neurological sequelae preventing participation in the respiratory rehabilitation program * Psychiatric, cognitive or linguistic disorders with inability to understand to follow the protocol * Patient with a contraindication to respiratory rehabilitation or any pathology preventing physical rehabilitation * Patient with a cardiovascular contraindication to respiratory rehabilitation * Person deprived of liberty by an administrative or judicial decision or person placed under judicial safeguard, guardianship or curatorship * Person subject to a legal protection measure * Pregnant or parturient or breastfeeding woman
Where it's running
-
Chu Rouen
Rouen, France Recruiting -
Chu Amiens
Amiens, France Not yet recruiting -
Gh Le Havre
Le Havre, France Not yet recruiting -
Centre de Sante Adir
Rouen, France Not yet recruiting
Study contacts
- Study coordinator: Marie-Anne Melone, MD, PhD
- Email: marieanne.melone@chu-rouen.fr
- Phone: (+33) 0232888265
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia
This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
Biologics for Type 2 Inflammation in Asthma and COPD in Real World
This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.
-
Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers
This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.
-
New breathing tests to diagnose airway disease in hospital and community settings
This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.